Cholinesterase inhibitor to prevent falls in Parkinson’s disease (CHIEF-PD) trial: a phase 3 randomised, double-blind placebo-controlled trial of rivastigmine to prevent falls in Parkinson’s diseaseSandra Neumann, Emily J. Henderson, Alison Bamford et al.|BMC Neurology|2021Cited by 22